IP Library Granted Patent US 8,414,749
Granted Patent B2
US 8,414,749 · App. 12/269,800 · Granted Apr 9, 2013

Subcutaneous glucose electrode

Inventors: Adam Heller (Austin, TX); Michael V. Pishko (Austin, TX)
Assignee: Abbott Diabetes Care Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,414,749
App. No.
12/269,800
Granted
Apr 9, 2013
Kind
B2
Abstract

A small diameter flexible electrode designed for subcutaneous in vivo amperometric monitoring of glucose is described. The electrode is designed to allow “one-point” in vivo calibration, i.e., to have zero output current at zero glucose concentration, even in the presence of other electroreactive species of serum or blood. The electrode is preferably layered, with the layers serially deposited within a recess upon the tip of a polyamide insulated gold wire. A first glucose concentration-to-current transducing layer can be overcoated with an electrically insulating and glucose flux limiting layer (second layer) on which, optionally, an immobilized interference-eliminating horseradish peroxidase based film is deposited. An outer layer is preferably biocompatible.

Claims (34)

1. An analyte sensor comprising:

one or more working electrodes;

an analyte-responsive sensing layer associated with and in electrical contact with the one or more working electrodes, the sensing layer comprising an enzyme and a polymer selected from the group consisting of poly(vinylimidazole) and poly(vinyl pyridine); and

a polymeric diffusion-limiting layer disposed on and bound to the analyte-responsive sensing layer,

wherein at least a portion of the sensor is subcutaneously positioned in a subject.

2. The analyte sensor of claim 1 , wherein the analyte is glucose and the enzyme is glucose oxidase.

3. The analyte sensor of claim 2 , wherein the analyte sensor has a 10% to 90% response time of not more than about 30 second at a glucose concentration of about 20 mM.

4. The analyte sensor of claim 2 , wherein sensor response to glucose is close to linear through a glucose concentration range of 2 to 20 mM.

5. The analyte sensor of claim 2 , wherein the analyte sensor has substantially no signal output when concentration of glucose is zero.

6. The analyte sensor of claim 1 , wherein the enzyme is covalently bound to the polymer.

7. The analyte sensor of claim 1 , the sensing layer further comprising a redox compound.

8. The analyte sensor of claim 7 , wherein the redox compound is covalently bound to the polymer.

9. The analyte sensor of claim 8 , wherein the enzyme is covalently bound to the polymer.

10. The analyte sensor of claim 1 , wherein the polymeric diffusion-limiting layer limits the rate of analyte transport to the sensing layer.

11. The analyte sensor of claim 1 , further comprising one or more additional layers.

12. The analyte sensor of claim 11 , wherein the one or more additional layers comprises at least one of a biocompatible layer or an interferant eliminating layer.

13. The analyte sensor of claim 1 , wherein the sensor comprises a first portion and a second portion, wherein the first portion is positioned external to the subject and the second portion is positioned subcutaneously in the subject.

14. The analyte sensor of claim 13 , wherein the first portion is connected to a device for measurement of the electrical signal generated by the sensor.

15. The analyte sensor of claim 13 , wherein the second portion of the analyte sensor has a width of no more than about 0.29 mm.

16. The analyte sensor of claim 1 , wherein the sensor has substantially no signal output when the concentration of glucose is zero.

17. The analyte sensor of claim 1 , wherein the sensor comprises at least two electrodes and at least one of the electrodes is a working electrode and at least one other electrode is a reference electrode, a counter electrode or a combined reference and counter electrode.

18. The analyte sensor of claim 1 , wherein one or more working electrodes is a wire.

19. The analyte sensor of claim 1 , wherein the sensor is flexible and provides an electrical signal that is substantially insensitive to relative motion between the implanted portion of the sensor and tissue surrounding the implanted portion of the sensor.

20. The analyte sensor of claim 1 , wherein the sensor has an in vivo glucose sensitivity of from about 10 pA/mg/dL to about 250 pA/mg/dL.

21. The analyte sensor of claim 20 , wherein the in vivo glucose sensitivity does not change by more than about ±5% for 72 hours of operation at 37° C.

22. The analyte sensor of claim 1 , wherein the analyte-responsive sensing layer and the polymeric diffusion-limiting layer are formed in situ on the working electrode.

23. The analyte sensor of claim 1 , wherein the analyte sensor comprises a wire.

24. The analyte sensor of claim 1 , wherein the working electrode has a width of no more than about 0.25 mm.

25. The analyte sensor of claim 1 , wherein the analyte sensor measures an analyte concentration in a host such that at least 80% of measured sensor values from the analyte sensor are within 20% of actual analyte values.

26. An analyte sensor comprising:

an electrode comprising a metal wire;

an analyte-responsive sensing layer associated with the wire, the sensing layer comprising an enzyme and a polymer selected from the group consisting of poly(vinylimidazole) and poly(vinyl pyridine); and

a polymeric diffusion-limiting layer disposed on and bound to the analyte responsive-sensing layer.

27. The analyte sensor of claim 26 , wherein the analyte sensor measures an analyte concentration in a host such that at least 80% of measured sensor values from the analyte sensor are within 20% of actual analyte values.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2009
From: HELLER, ADAM
To: E. HELLER & COMPANY
Reel/Frame 023528/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2009
From: PISHKO, MICHAEL V.
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 023528/0464 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2009
From: E. HELLER & COMPANY
To: THERASENSE, INC.
Reel/Frame 023528/0488 →
RATIFICATION OF ASSIGNMENTS Recorded Nov 17, 2009
From: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
To: THERASENSE, INC.
Reel/Frame 023528/0547 →
CHANGE OF NAME Recorded Nov 17, 2009
From: THERASENSE, INC.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 023528/0587 →
Continuity (10)
Continuation 11182634 · Jul 15, 2005
Continuation 11109379 · Apr 19, 2005
Continuation 10353341 · Jan 28, 2003
Continuation 09997808 · Nov 29, 2001
Continuation 09668221 · Sep 22, 2000
Continuation 09477053 · Jan 3, 2000
Continuation 09356102 · Jul 16, 1999
Continuation 08767110 · Dec 4, 1996
Continuation 08299526 · Sep 1, 1994
Related Publication 20090137889A1 · May 28, 2009